-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Depreciation history and growth rate from 2016 to 2023.
- Autolus Therapeutics plc Depreciation for the quarter ending June 30, 2024 was $1.9M, a 26.7% increase year-over-year.
- Autolus Therapeutics plc Depreciation for the twelve months ending June 30, 2024 was $6.9M.
- Autolus Therapeutics plc annual Depreciation for 2023 was $6.6M, a 9.59% decline from 2022.
- Autolus Therapeutics plc annual Depreciation for 2022 was $7.3M, a 15.1% decline from 2021.
- Autolus Therapeutics plc annual Depreciation for 2021 was $8.6M, a 50.9% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)